comparemela.com

Latest Breaking News On - Tania de jong - Page 7 : comparemela.com

MDMA and psilocybin not approved for medicinal use in Australia

MDMA and psilocybin not approved for medicinal use in Australia The Therapeutic Goods Administration (TGA) has made an interim decision on whether some psychoactive drugs can be used to treat mental illness in Australia. The TGA chose not to reschedule MDMA and psilocybin, the active ingredient in magic mushrooms, from a prohibited substance (schedule 9) to a controlled medicine (schedule 8). A reclassification would not mean the drugs could be taken home with a patient or change any restrictions on recreational use of the substances. READ MORE: Peter Hunt and Tania De Jong, co-founders of Mind Medicine Australia.(Supplied) Mind Medicine Australia initially submitted the rescheduling applications to the TGA in July 2020, and now have a number of weeks to resubmit evidence.

MDMA and psilocybin could be approved for medicinal use in Australia

MDMA and psilocybin could be approved for medicinal use in Australia A decision on whether some psychoactive drugs can be used to treat mental illness in Australia will be handed down this week. The Therapeutic Goods Administration (TGA) is due to release an interim decision on the rescheduling of MDMA and psilocybin - the active ingredient in magic mushrooms - tomorrow. If approved these drugs would be reclassified from a prohibited substance (schedule 9) to a controlled medicine (schedule 8). READ MORE: Peter Hunt and Tania De Jong, co-founders of Mind Medicine Australia.(Supplied) This would clear the way for them to be used in clinical therapy for treatment-resistant depression, post traumatic stress disorder (PTSD) and other complex mental illnesses.

Party drugs to be used to treat sick Aussies

Health by Amelia Saw Premium Content   Exclusive: In the first course of its kind in the southern hemisphere, 100 Australian doctors, psychiatrists, psychologists, mental health care nurses, social workers and occupational therapists will be trained and ready to treat patients with party drugs such as MDMA and magic mushrooms. Course providers Mind Medicine Australia expect the first patients to be treated include those suffering from PTSD, depression, anxiety, obsessive compulsive disorder, and anorexia. Participating GP Dr Jamie Rickcord, who has worked in the NSW Northern Rivers for the past eight years, signed up for the $7000 course after finding current approaches to mental health treatment were not producing satisfactory outcomes.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.